Semipermeable hollow fiber membranes in hepatocyte bioreactors: a prerequisite for a successful bioartificial liver? 1997

L M Flendrig, and A A te Velde, and R A Chamuleau
Department of Experimental Internal Medicine, University of Amsterdam, Academic Medical Center, The Netherlands.

Recent studies have shown that liver support systems based on viable hepatocytes can prolong life in animal models of acute liver failure. Now the time has come to elucidate the design characteristics that are essential to construct an efficient bioreactor. The gold standard remains the intact liver. Despite the very high cell density in this organ, individual cell perfusion is guaranteed resulting in low diffusional gradients which are essential for optimal mass transfer. These conditions are not met in bioreactors based on hollow fiber membranes. Moreover, the semipermeable membranes can foul and act as a diffusional barrier between the hepatocytes and the blood or plasma of the recipient. We devised a novel bioreactor for use as a bioartificial liver that does not include hollow fiber membranes for blood or plasma perfusion. The device is based on an integral oxygenator and a nonwoven polyester matrix material for hepatocyte culture as small aggregates. The efficacy of this original design was tested in rats with liver ischemia. Preliminary results show statistically significantly improved survival; life was prolonged 100% compared to the control experiments.

UI MeSH Term Description Entries
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008567 Membranes, Artificial Artificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis (RENAL DIALYSIS), monomolecular and bimolecular membranes used as models to simulate biological CELL MEMBRANES. These membranes are also used in the process of GUIDED TISSUE REGENERATION. Artificial Membranes,Artificial Membrane,Membrane, Artificial
D010106 Oxygenators Devices which mechanically oxygenate venous blood extracorporeally. They are used in combination with one or more pumps for maintaining circulation during open heart surgery and for assisting the circulation in patients seriously ill with some cardiac and pulmonary disorders. (UMDNS, 1999) Oxygenator
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

L M Flendrig, and A A te Velde, and R A Chamuleau
January 2004, Annals of clinical and laboratory science,
L M Flendrig, and A A te Velde, and R A Chamuleau
December 1992, The Journal of surgical research,
L M Flendrig, and A A te Velde, and R A Chamuleau
October 1996, Biotechnology and bioengineering,
L M Flendrig, and A A te Velde, and R A Chamuleau
January 1993, Biotechnology and bioengineering,
L M Flendrig, and A A te Velde, and R A Chamuleau
January 1995, Tissue engineering,
L M Flendrig, and A A te Velde, and R A Chamuleau
October 1996, The International journal of artificial organs,
L M Flendrig, and A A te Velde, and R A Chamuleau
January 2022, Cells, tissues, organs,
L M Flendrig, and A A te Velde, and R A Chamuleau
September 2019, Colloids and surfaces. B, Biointerfaces,
L M Flendrig, and A A te Velde, and R A Chamuleau
April 2000, Transplantation,
L M Flendrig, and A A te Velde, and R A Chamuleau
November 2003, Artificial organs,
Copied contents to your clipboard!